Standort: Switzerland ÄndernSchließen

Aktieninformationen

Aktienkurs | Kotierung | Bedeutende Aktionäre | Dividende | Werttransfer an Aktionäre | Analysten | Analystenschätzungen

Landis+Gyr ist seit Juli 2017 an der SIX Swiss Exchange kotiert.

Aktienkurs

Kotierung

KotierungSIX Swiss Exchange (International Reporting Standard)
TickersymbolLAND
Valorennummer37115349
ISINCH0371153492
NominalwertCHF 10.00
Ausstehende Aktien29,251,249
IndicesSPI, SPI Extra, SPI ex SLI, Swiss All Share Index, UBS 100 Index, Ethos Swiss Governance Index, STOXX® All Europe 800
RechnungslegungsstandardUS GAAP
AuditorPricewaterhouseCoopers

Bedeutende Aktionäre

AktionärAnzahl Aktien% der Stimmrechte
KIRKBI Invest A/S, Denmark4,445,26515.20%
Rudolf Maag, Switzerland3,000,00010.26%
JPMorgan Chase & Co, United States920,2963.15%

Alle Offenlegungsmeldungen von wesentlichen Beteiligungen finden Sie auf der Webseite der SIX Exchange Regulation: www.six-exchange-regulation.com

Dividende & Steuerwert

Die Dividendenpolitik von Landis+Gyr strebt eine nachhaltige Dividendenausschüttung von mindestens 75% des Free Cashflows (ohne M&A) an. Die zur Ausschüttung verfügbaren Kapitaleinlagereserven betrugen per 30. September 2019 rund CHF 888.4 Mio.

JahrSteuerwertDividendeDetails
201777.60-ICTax
201855.152.301)ICTax
2019100.703.151)ICTax

1) Ausschüttung aus Kapitaleinlagereserven

Werttransfer an Aktionär

Millionen CHFDividendeAktienrückkaufTotal
201867.9-67.9
201991.733.7125.4
Total159.633.7193.3

Analysten

Die nachfolgenden Analysten decken Landis+Gyr ab (letzter Update Februar 2020).

InstitutionAnalystKontaktEmpfehlung
CowenJeffrey Osborne[email protected]
+1 (646) 562 1391
Outperform
Credit SuissePatrick Laager[email protected]
+41 44 334 60 76
Outperform
J.P. MorganAndreas Willi[email protected]
+44 20 7134 4569
Underweight
MirabaudDaniel König[email protected]
+41 58 816 8872
Neutral
MizuhoMarvin Lo[email protected]
+852 2685 2031
Buy
Morgan StanleyBen Uglow[email protected]
+44 20 7425 8750
Underweight
Research PartnersUrs Emminger[email protected]
+41 44 533 40 30
Buy
UBSFabian Haecki[email protected]
+41 44 239 1347
Neutral
VontobelMark Diethelm[email protected]
+41 58 283 71 82
Reduce

Analysten-Konsensschätzungen

Nachstehend finden Sie die aktuellen Analysten-Konsensschätzungen. Sie werden von Investor Relations jedes Quartal von Sell-Side-Analysten, welche Landis+Gyr verfolgen, zusammengetragen.

Kennzahlen (Mio. USD)Geschäftsjahr 2019/20 (n=7)Geschäftsjahr 2020/21 (n=7)Geschäftsjahr 2021/22 (n=7)
Net revenues1,8071,8721,935
Adjusted EBITDA253272282
Free Cash Flow131146154
Dividend per Share (CHF)3.364.024.36

Disclaimer:

The estimates and any related opinions, forecasts, projections, predictions or expectations, are the sole responsibility of the analysts concerned. Landis+Gyr Group AG has not commented on nor verified any (individual) estimates and it does not express any opinion on nor endorses the estimates or their correctness and accuracy in any way. Landis+Gyr Group AG accepts no liability in respect of the analyst consensus and undertakes no obligation to provide updates or revisions.

It should be noted that estimates are, by definition, forward looking and are therefore subject to risks and uncertainties which are subject to change at any time and which may materially affect eventual results.

This analyst consensus is provided for information purposes only. It should not be seen as a recommendation to buy or sell financial instruments in Landis+Gyr Group AG, or to take or refrain from taking any other action.

 

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close